'We're ahead of the pack' in the cannabinoid drug space, says CEO of synthetic drugmaker Corbus

6:51 PM ET Thu, 20 Sept 2018

Jim Cramer sits down with Yuval Cohen, the CEO of a company that is creating treatments derived from manmade cannabinoids for rare diseases like cystic fibrosis.